Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL Cholesterol
Clinical trial NCT06750341 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06750341
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-01
- Primary completion
- 2026-06-01
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.